\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes HealthThe Commission launched a targeted consultation on the 2023 EU4Health programme. Deadline: 27 June 2022
The aim is to gather stakeholders’ opinions about current and future EU health priorities, strategic orientations and key health needs to be addressed through EU4Health annual work programmes, as well as providing inputs for reflection on the 2023 EU4Health Work Programme and beyond.
Within the Work Programme, the actions are structured as follows:
The link to the Survey can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
